Explore alternatives to semaglutide for diabetes and weight loss, including medications like metformin, liraglutide, and orlistat, tailored to your health needs.
As awareness of GLP-1 medications grows, many individuals are considering different treatment options in consultation with licensed healthcare providers. Whether you’re navigating side effects, evaluating cost, or exploring alternatives, understanding which FDA-approved options are available can support more informed conversations about your care.
This guide offers an educational overview of GLP-1 medications and related therapies that individuals may wish to discuss with a licensed healthcare professional.
Disclaimer: This article is for general informational purposes only and does not constitute medical advice. Eden does not practice medicine or prescribe medications. Please consult a licensed healthcare provider to determine best practices for your health.
Semaglutide belongs to a class of prescription medications known as GLP-1 receptor agonists. These medications mimic the action of a natural hormone involved in regulating appetite and digestion.
FDA-approved forms of semaglutide include injectable and oral options marketed under brand names like Ozempic®, Wegovy®, and Rybelsus®. These medications are not affiliated with Eden. Each is approved for specific indications, which patients can review with a licensed healthcare provider.
Below are FDA-approved medications that patients may wish to discuss with a licensed healthcare provider. Each medication has unique characteristics and approved uses, and potential effects can vary based on individual health history and provider evaluation..
Tirzepatide is a dual GIP and GLP-1 receptor agonist. FDA-approved under the brand names Mounjaro® for type 2 diabetes and as Zepbound® for chronic weight management.
Individuals should speak with a licensed healthcare provider to determine whether this medication is appropriate based on their health history and medical evaluation.
Rybelsus® is currently the only FDA-approved oral formulation of semaglutide. It is indicated for the treatment of type 2 diabetes. Individuals interested in non-injectable options should consult a licensed healthcare provider to determine whether this medication is appropriate for their health needs.
Wegovy® is an injectable prescription medication that contains semaglutide and is FDA-approved for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related health condition. It is often used alongside lifestyle changes under the supervision of a licensed healthcare provider who determines the most appropriate treatment approach for each individual.
Dulaglutide (Trulicity®) is a once-weekly GLP-1 receptor agonist indicated for the treatment of type 2 diabetes. It may also reduce cardiovascular risk in certain patients.
A licensed healthcare provider can determine whether this medication is appropriate based on your individual health profile and treatment needs.
Liraglutide is available in two FDA-approved formulations: Victoza®, for the treatment of type 2 diabetes, and Saxenda®, for chronic weight management.
Individuals should consult a licensed healthcare provider to determine whether either medication is appropriate based on their health history and clinical evaluation.
Some supplements, such as berberine or cinnamon, are marketed for general wellness or metabolic support. However, these products are not FDA-approved for the treatment of obesity or type 2 diabetes, and their effectiveness has not been established in large-scale clinical trials.
Always consult a licensed healthcare provider before adding supplements to your care plan.
Eden is a digital health platform that may help individuals connect with licensed healthcare providers who can evaluate whether GLP-1-based therapy may be appropriate based on each patient’s health history and goals. Through the Eden platform, licensed healthcare providers may:
Ready to take the next step? Connect with an independent, licensed healthcare provider through Eden to discuss whether GLP-1-based treatment options may be appropriate for your needs.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
